UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.328-335.e11

2010

Volltextzugriff (PDF)

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma

Journal of allergy and clinical immunology, 2014-06, Vol.133 (6), p.1549-1556

2014

Volltextzugriff (PDF)

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.332-342.e10

2012

Volltextzugriff (PDF)

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

Journal of allergy and clinical immunology, 2017-05, Vol.139 (5), p.1431-1444

2017

Volltextzugriff (PDF)

Real-world Evaluation of Asthma Control and Treatment (REACT): Findings from a national Web-based survey

Journal of allergy and clinical immunology, 2007-06, Vol.119 (6), p.1454-1461

2007

Volltextzugriff (PDF)

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Journal of allergy and clinical immunology, 2009-11, Vol.124 (5), p.895-902.e4

2009

Volltextzugriff (PDF)

A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study

Muscle & nerve, 2018-04, Vol.57 (4), p.550-560

2018

Volltextzugriff (PDF)

A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System

Orphanet journal of rare diseases, 2024-05, Vol.19 (1), p.188-188, Article 188

2024

Volltextzugriff (PDF)

Asthma exacerbations and lung function in patients with severe or difficult-to-treat asthma

Journal of allergy and clinical immunology, 2015-10, Vol.136 (4), p.1125-1127.e4

2015

Volltextzugriff (PDF)

Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States

Orphanet journal of rare diseases, 2023-06, Vol.18 (1), p.138-138, Article 138

2023

Volltextzugriff (PDF)

Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma

Chest, 2007-12, Vol.132 (6), p.1882-1889

2007

Volltextzugriff (PDF)

Impact of Socioeconomic Status, Race, and Ethnicity on Quality of Life in Patients With Cystic Fibrosis in the United States

Chest, 2010-03, Vol.137 (3), p.642-650

2010

Volltextzugriff (PDF)

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Annals of the American Thoracic Society, 2021-12, Vol.18 (12), p.1978-1987

2021

Volltextzugriff (PDF)

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

The Journal of pediatrics, 2009-11, Vol.155 (5), p.634-639.e4

2009

Volltextzugriff (PDF)

Economic burden of impairment in children with severe or difficult-to-treat asthma

Annals of allergy, asthma, & immunology, 2011-08, Vol.107 (2), p.110-119.e1

2011

Volltextzugriff (PDF)

Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-09, Vol.2 (5), p.544-552.e2

2014

Volltextzugriff (PDF)

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma

Journal of allergy and clinical immunology, 2009-11, Vol.124 (5), p.921-927

2009

Volltextzugriff (PDF)

Preferences in terminology used to describe oral immunotherapy varies based on physician utilization

The World Allergy Organization journal, 2020-08, Vol.13 (8), p.100309, Article 100309

2020

Volltextzugriff (PDF)

Incidence of anaphylaxis and accidental peanut exposure: A systematic review

Clinical and translational allergy, 2021-10, Vol.11 (8), p.e12064-n/a

2021

Volltextzugriff (PDF)

Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma

Annals of allergy, asthma, & immunology, 2015-06, Vol.114 (6), p.516-521.e2

2015

Volltextzugriff (PDF)

Baseline Blood Eosinophils and Reduction of Asthma Exacerbations By Omalizumab in Children with Moderate-to-Severe Allergic Asthma

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB83-AB83

2017

Volltextzugriff (PDF)

Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

Chronic respiratory disease, 2019, Vol.16, p.1479973119879678-1479973119879678

2019

Volltextzugriff (PDF)

Long-Term Outcomes from a Pediatric Subgroup of Tenor I: 10 Years Follow up

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB101-AB101

2017

Volltextzugriff (PDF)

Activity and School Impairment By EPR-3 Asthma Control Guidelines in Children with Severe or Difficult-to-Treat Asthma

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB101-AB101

2017

Volltextzugriff (PDF)

Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2014-03, Vol.2 (2), p.193-200.e3

2014

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(97)
Dissertationen
(2)

Sprache

Englisch
(99)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Humans
(49)
Allergy
(42)
Asthma
(42)
Immunology
(42)
Female
(35)
Male
(35)
Adult
(27)
Child
(26)
Allergy And Immunology
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Asthma - Drug Therapy
(23)
Adolescent
(22)
Middle Aged
(22)
Quality Of Life
(18)
Patients
(17)
Anti-Asthmatic Agents - Therapeutic Use
(15)
Epidemiology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions

Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma

Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

Real-world Evaluation of Asthma Control and Treatment (REACT): Findings from a national Web-based survey

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study

A healthcare claims analysis to identify and characterize patients with suspected X-Linked Myotubular Myopathy (XLMTM) in the Brazilian Healthcare System

Asthma exacerbations and lung function in patients with severe or difficult-to-treat asthma

Real-world analysis of healthcare resource utilization by patients with X-linked myotubular myopathy (XLMTM) in the United States

Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma

Impact of Socioeconomic Status, Race, and Ethnicity on Quality of Life in Patients With Cystic Fibrosis in the United States

A Comprehensive Analysis of the Stability of Blood Eosinophil Levels

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

Economic burden of impairment in children with severe or difficult-to-treat asthma

Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma

Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma

Preferences in terminology used to describe oral immunotherapy varies based on physician utilization

Incidence of anaphylaxis and accidental peanut exposure: A systematic review

Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma

Baseline Blood Eosinophils and Reduction of Asthma Exacerbations By Omalizumab in Children with Moderate-to-Severe Allergic Asthma

Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

Long-Term Outcomes from a Pediatric Subgroup of Tenor I: 10 Years Follow up

Activity and School Impairment By EPR-3 Asthma Control Guidelines in Children with Severe or Difficult-to-Treat Asthma

Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort

Suchergebnisse filtern